Pharmacological Studies of FUT-175, Nafamostat Mesilate V. Effects on the Pancreatic Enzymes and Experimental Acute Pancreatitis in Rats-Reference-Cited by-同舟云学术

Pharmacological Studies of FUT-175, Nafamostat Mesilate V. Effects on the Pancreatic Enzymes and Experimental Acute Pancreatitis in Rats

Published:1986 Issue:2 Volume:41 Page:155-162
ISSN:0021-5198
Container-title:Japanese Journal of Pharmacology
language:en
Short-container-title:Japanese Journal of Pharmacology

Author:

IWAKI Masahiro,INO Yoshilaka,MOTOYOSHI Akemi,OZEKI Masayuki,SATO Takuo,KURUMI Masateru,AOYAMA Takuo

Publisher

Elsevier BV

Subject

Pharmacology

Reference14 articles.

1. New synthetic inhibitors of C1r. C1 esterase. thrombin. plasrrun. kallikrean and trypsin;Fujli;Biochim. Biophys. Acta,1981

2. Pharmacological studies of FUT-175. nafamstat mesilale. I. Inhibition of protease activity in in vitro and in vivo experiments. Japan;Aoyama;J. Pharmacol.,1984

3. Pharmacological studies of FUT-175. nafamstat mesi-ate H. Effects on experimental acute pancreatitis;Iwaki;Folia Pharmacol. Japon.,1984

4. Aetiology and pathogenesis of pancreatitis (Current concepts);Creutzfeldt;Scand J. Gastroenterol. Supp.,1970

5. The role of pancreatic enzymes in the pathogenesis of acute pancreatitis. II. The fate of pancreatic proteolytic enzymes in the course of acute pancreatitis;Beck;Gastroenterology,1962

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiological dynamics in the contact, coagulation, and complement systems during sepsis: Potential targets for nafamostat mesilate;Journal of Intensive Medicine;2024-10

2. The role of nafamostat mesylate anticoagulation in continuous kidney replacement therapy for critically ill patients with bleeding tendencies: a retrospective study on patient outcomes and safety;Kidney Research and Clinical Practice;2024-07-31

3. Nafamostat Reduces the Incidence of post‐ERCP Pancreatitis: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials;Clinical Pharmacology & Therapeutics;2023-12-29

4. Mechanisms of NMDA Receptor Inhibition by Sepimostat—Comparison with Nafamostat and Diarylamidine Compounds;International Journal of Molecular Sciences;2023-10-27

5. Nafamostat mesilate for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis based on prospective, randomized, and controlled trials;Medicine;2023-10-13